Boston Scientific Corp (BSX)
73.69
-0.41
(-0.55%)
USD |
NYSE |
May 10, 16:00
73.68
-0.01
(-0.01%)
Pre-Market: 20:00
Boston Scientific Gross Profit (TTM): 10.18B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 10.18B |
December 31, 2023 | 9.882B |
September 30, 2023 | 9.535B |
June 30, 2023 | 9.30B |
March 31, 2023 | 8.993B |
December 31, 2022 | 8.715B |
September 30, 2022 | 8.677B |
June 30, 2022 | 8.504B |
March 31, 2022 | 8.402B |
December 31, 2021 | 8.177B |
September 30, 2021 | 7.68B |
June 30, 2021 | 7.44B |
March 31, 2021 | 6.524B |
December 31, 2020 | 6.403B |
September 30, 2020 | 6.743B |
June 30, 2020 | 6.88B |
March 31, 2020 | 7.532B |
December 31, 2019 | 7.554B |
September 30, 2019 | 7.332B |
June 30, 2019 | 7.121B |
March 31, 2019 | 6.999B |
December 31, 2018 | 6.941B |
September 30, 2018 | 6.843B |
June 30, 2018 | 6.708B |
March 31, 2018 | 6.582B |
Date | Value |
---|---|
December 31, 2017 | 6.386B |
September 30, 2017 | 6.222B |
June 30, 2017 | 6.144B |
March 31, 2017 | 6.003B |
December 31, 2016 | 5.882B |
September 30, 2016 | 5.718B |
June 30, 2016 | 5.559B |
March 31, 2016 | 5.377B |
December 31, 2015 | 5.236B |
September 30, 2015 | 5.151B |
June 30, 2015 | 5.094B |
March 31, 2015 | 5.094B |
December 31, 2014 | 5.06B |
September 30, 2014 | 5.014B |
June 30, 2014 | 4.936B |
March 31, 2014 | 4.883B |
December 31, 2013 | 4.828B |
September 30, 2013 | 4.782B |
June 30, 2013 | 4.733B |
March 31, 2013 | 4.703B |
December 31, 2012 | 4.748B |
September 30, 2012 | 4.553B |
June 30, 2012 | 4.599B |
March 31, 2012 | 4.684B |
December 31, 2011 | 4.791B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
6.403B
Minimum
Dec 2020
10.18B
Maximum
Mar 2024
8.079B
Average
7.928B
Median
Gross Profit (TTM) Benchmarks
ResMed Inc | 2.557B |
Stryker Corp | 13.38B |
Align Technology Inc | 2.744B |
Abbott Laboratories | 22.22B |
Axonics Inc | 291.31M |